NCT04905719

Point-of-Care Ultrasound in Primary Care

Name: Clinical Trial NCT04905719
Creator: Emergency Medical Service of the Central Bohemian Region, Czech Republic
Keywords: Ultrasound, Ultrasound, diagnostic test, clinical trial, Czech

Reliability of Point-of-Care Ultrasound Examination in Primary Care Performed by a General Practitioner

Emergency Medical Service of the Central Bohemian Region, Czech Republic·ClinicalTrials.gov·diagnostic testRecruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Ultrasound
Drug/Device/Intervention: Ultrasound
Study type: Observational
Intervention type: diagnostic test

Sponsor & location

Primary sponsor: Emergency Medical Service of the Central Bohemian Region, Czech Republic
Location: Usti nad Labem, Czech

Timeline & enrollment

Phase: N/A
Start date: Jun 10, 2021
End date: Jun 30, 2022
Enrollment: 600 participants

Primary outcome

Reliability of Point-of-Care ultrasound investigation of the lungs, gall bladder or proximal deep veins of lower extremities performed by general practitioner compared with the expert diagnostic method

Summary

The purpose of this study is to evaluate reliability of Point-of-Care ultrasound evaluation performed by general practitioners.

ICD-10 classifications

Abnormal ultrasonic finding on antenatal screening of motherAntenatal screening for malformations using ultrasound and other physical methodsAntenatal screening for fetal growth retardation using ultrasound and other physical methodsOther diagnostic agentsExamination of ears and hearing

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT04905719
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT04905719 through Pure Global AI's free database. This phase not specified trial is sponsored by Emergency Medical Service of the Central Bohemian Region, Czech Republic and is currently Recruiting. The study focuses on Ultrasound. Target enrollment is 600 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.